Maplight Therapeutics (NASDAQ:MPLT) Director Acquires $77,694.54 in Stock

NodeGuardian · 2026-02-26T08:42:50+00:00

Maplight Therapeutics Director George Pavlov purchased 4,422 shares, boosting his stake by over 40%. The stock trades at $17.88, with a market cap of $811.27 million, and analysts give it a "Moderate Buy" rating despite recent EPS losses.

NodeGuardian

2026-02-26 08:42:50

Abstract generation in progress

Maplight Therapeutics (NASDAQ:MPLT) Director George Pavlov recently acquired 4,422 shares totaling $77,694.54, increasing his stake by over 40%. These purchases occurred between February 18th and 20th and were disclosed in SEC filings. The company’s stock is trading around $17.88, has a market cap of $811.27 million, and has received a “Moderate Buy” consensus rating from analysts with an average target price of $31.00, despite recently reporting a significant EPS loss.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.